The ARQL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARQL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARQL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARQL Detailed Price Forecast - CNN Money||View ARQL Detailed Summary - Google Finance|
|View ARQL Detailed Summary - Yahoo! Finance||View ARQL Stock Research & Analysis - Zacks.com|
|View ARQL Trends & Analysis - Trade-Ideas||View ARQL Major Holders - Barrons|
|View ARQL Call Transcripts - NASDAQ||View ARQL Breaking News & Analysis - Seeking Alpha|
|View ARQL Annual Report - CompanySpotlight.com||View ARQL OTC Short Report - OTCShortReport.com|
|View ARQL Fundamentals - TradeKing||View ARQL SEC Filings - Bar Chart|
|View Historical Prices for ARQL - The WSJ||View Performance/Total Return for ARQL - Morningstar|
|View the Analyst Estimates for ARQL - MarketWatch||View the Earnings History for ARQL - CNBC|
|View the ARQL Earnings - StockMarketWatch||View ARQL Buy or Sell Recommendations - MacroAxis|
|View the ARQL Bullish Patterns - American Bulls||View ARQL Short Pain Metrics - ShortPainBot.com|
|View ARQL Stock Mentions - StockTwits||View ARQL Stock Mentions - PennyStockTweets|
|View ARQL Stock Mentions - Twitter||View ARQL Investment Forum News - Investor Hub|
|View ARQL Stock Mentions - Yahoo! Message Board||View ARQL Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARQL - SECform4.com||View Insider Transactions for ARQL - Insider Cow|
|View ARQL Major Holdings Summary - CNBC||View Insider Disclosure for ARQL - OTC Markets|
|View Insider Transactions for ARQL - Yahoo! Finance||View Institutional Holdings for ARQL - NASDAQ|
|View ARQL Stock Insight & Charts - FinViz.com||View ARQL Investment Charts - StockCharts.com|
|View ARQL Stock Overview & Charts - BarChart||View ARQL User Generated Charts - Trading View|
Wired News – ArQule Inked Exclusive License Deal with Basilea for Derazantinib in the US, EU, Japan and Rest of World
Posted on Thursday April 19, 2018
Stock Monitor: Hemispherx Biopharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 19, 2018 / Active-Investors.com has just released a free research report on ArQule, Inc. (NASDAQ: ARQL ). If ...
Benzinga Pro's 5 Stocks To Watch Today
Posted on Tuesday April 17, 2018
Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user ! Netflix, Inc. (NASDAQ: NFLX ) shares gained around ...
ArQule, Inc. today announced that it has entered into an exclusive license agreement with Basilea Pharmaceutica International Limited to develop and commercialize derazantinib, a pan-FGFR inhibitor in the US, EU, Japan and rest of the world excluding the People’s Republic of China, Hong Kong, Macau and Taiwan, where Sinovant Sciences Ltd., a Roivant Sciences Ltd.
Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
Posted on Monday April 16, 2018
Basel, Switzerland, April 17, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into a license agreement with ArQule, Inc. (NASDAQ: ARQL) for its oncology drug candidate ...